The expansion of the Food sector, the increasing awareness about vitamin K deficiency, and the rising demand for Dietary supplements have resulted in boosting the Phylloquinone market.
Phylloquinone Market Size – USD 413.7 Million in 2018, Growth - CAGR of 7.8%, Trends – The rising demand for Phylloquinone in dietary supplements
The Global Phylloquinone Market is forecast to reach USD 820.0 Million by 2027, according to a new report by Reports and Data. Phylloquinone can be described as a prenylated naphthoquinone, which is synthesized exclusively by green algae, certain species of cyanobacteria, plants wherein it acts as an electron acceptor for developing protein disulfide bonds, and as an essential electron carrier in photosystem I. This prenylated naphthoquinone is also referred as vitamin K1. This type of vitamin K is stable in moisture air, and it is fat-soluble. However, this type of vitamin K degrades in sunlight. One of its mentionable natural source is green plants. It is also considered as an antidote for coumatetralyl. Vitamin K plays an essential role in the posttranslational modification of some proteins, which is mostly needed for blood coagulation. In recent years, there has been an elevating focus on vitamin K as a beneficial nutrient in cardiovascular health. This form of vitamin K is the most common dietary source of this vitamin, which is available in some plant oils and dark-green leafy vegetables. Based on various animal studies, it has been stated that the intake of this vitamin may help in minimizing the development of CVD by regulating lipoprotein metabolism and counteracting vascular calcification. Thus, the rising occurrence rate of cardiovascular diseases, growing geriatric population are some of the mentionable factors contributing to the overall growth of the sector.
Get a sample of the report https://www.reportsanddata.com/sample-enquiry-form/2779
Top Leading Players: Amphastar Pharmaceuticals Inc., Country Life (Kikkoman Corporation), BASF, Kappa Bioscience, DSM, NattoPharma, Livealth Biopharma, NOW Foods, Solgar Inc and Pfizer Inc.
Further key findings from the report suggest
- The Phylloquinone market held a market share of USD 413.7 Million in the year 2018 that is forecasted to grow at a rate of 7.8% during the forecast period.
- In context to Grade, the Food Grade segment is projected to witness a faster growth rate of 8.1% during the forecast period, which occupied more than 40.0% of the market in 2018. The growth rate witnessed by the Food Grade segment is attributed to increasing demand for dietary supplements and elevating demand of the vitamin in the food sector in these dietary supplement products, which is contributing to the growth rate witnessed by this segment. It natural availability in various food sources like green leafy vegetables, and it’s easily availability also contributes to the growth rate witnessed by this segment.
- In context to Route of Administration, the Oral segment held the largest market share of 40.0% in 2018, with a CAGR of 7.9% during the forecast period. The wide availability of this vitamin in tablets, capsule, and other supplement forms and the ease of its consumption in the oral route of administration contributes to the growth rate witnessed by this segment.
- In regards to Application, the Osteoporosis segment is projected to witness the fastest growth rate of 8.5% during the forecast period, which is expected to hold 18.0% of the market by 2027. The growth rate witnessed by the Osteoporosis segment is attributed to the continuous rise in the geriatric population, the increasing occurrence rate of the condition, and applicability of the vitamin in its treatment, which contributes to the growth rate witnessed by this segment. The applicability of vitamin K1 in the treatment of osteoporosis has been shown to help in maintaining bone mineral density.
- In regards to the region, Europe is projected to witness a considerable growth rate of 8.0% during the forecast period, which is expected to hold more than 20.0% of the market by 2027. The growth rate witnessed by the Europe region is attributed to the continuous growth of the pharmaceutical sector, rising geriatric population, and increasing incidence rate of conditions like osteoporosis, which contributes to the expansion of the market in this region.
To know more about the report https://www.reportsanddata.com/report-detail/phylloquinone-market
Market Segmentation:
Grade Outlook (Volume, Kilo Tons; Revenue, USD Million; 2016-2027)
- Food Grade
- Pharmaceutical Grade
Route of Administration Outlook (Volume, Kilo Tons; Revenue, USD Million; 2016-2027)
- Parental
- Oral
- Topical
Application Outlook (Volume, Kilo Tons; Revenue, USD Million; 2016-2027)
- Vitamin K deficiency
- Warfarin overdose
- Obstructive jaundice
- Osteoporosis
- Others
Regional Outlook:
North America (U.S.A., Canada, Mexico)
Europe (Italy, U.K., Germany, France, Rest of Europe)
Asia Pacific (India, China, Japan, South Korea, Australia, Rest of Asia Pacific)
Latin America (Chile, Brazil, Argentina, Peru, Rest of Latin America)
Middle East Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East Africa)
To Get Insights Speak to Analyst https://www.reportsanddata.com/inquiry-before-buying/2779
Key questions covered in the global Phylloquinone Market report:
- What is the expected market size of the global Phylloquinone Market during the forecast period?
- What factors are expected to hamper global Phylloquinone Market growth over the forecast period?
- Which application segment is expected to dominate other application segments over the forecast period?
- Which region is expected to dominate in terms of revenue during the forecast period?
- What are the key outcomes of Porter’s Five Forces analysis and SWOT analysis?
- Which leading players are operating in the global Phylloquinone Market?
Request a customization of the report https://www.reportsanddata.com/request-customization-form/2779
Thank you for reading the report. Kindly contact us to know more about the customization plan that we offer as per client requirement. Our team will ensure that the report is well suited as per your requirement.
Browse More Reports:
About Us:
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behaviour shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs | Insights
Read the innovative blog at https://www.reportsanddata.com/blogs
Check out our upcoming research report at https://www.reportsanddata.com/upcoming-reports
